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By use of the parental hybridoma cell line 63F2A2 that produces specific antibodies of immunoglobulin 
isotype G1 (IgGl; 63F2A2.1) against Pfs230, we attempted to enrich for the synthesis of the downstream switch 
variant IgG2b and IgG2a monoclonal antibodies (MAbs) of the hybridoma cell line (63F2A2.2b and 63F2A2.2a, 
respectively). The parental IgGl did not reduce the Plasmodium falciparum transmission in a bioassay irre­
spective of the presence of complement. MAbs 63F2A2.2b and 63F2A2.2a were effective in reducing the 
infectivity of P. falciparum parasites to Anopheles gambiae mosquitoes in membrane-feeding experiments. A 
transmission reduction of 91% was accomplished by the 63F2A2.2b switch variant, and a reduction of greater 
than 99% was accomplished by the 63F2A2.2a switch variant, but only in the presence of active human 
complement. Subsequently, the transmission-reducing effect of MAb 63F2A2.2b or 63F2A2.2a was confirmed in 
vitro by the rapid lysis of newly formed macrogametes or zygotes in the presence of active complement. MAb 
63F2A2.1 did not lyse the newly formed macrogametes or zygotes irrespective of the presence of complement.
Malaria is transmitted from humans to mosquitoes through 
gametocytes that develop in the blood of infected patients. 
Gametogenesis of Plasmodium falciparum in the Anopheles 
mosquito midgut is accompanied by the emergence of the 
gamétocyte from the erythrocyte. From that moment, the ex­
tracellular parasites become susceptible to immune factors, 
such as antibodies and complement, taken up during the blood 
meal from the vertebrate host (4),
Gametocytes of P. falciparum synthesize moleciiles with ap­
parent molecular sizes of 230 and of 48 and 45 kDa (Pfs230 
and Pfs48/45) after extraction with sodium dodecyl sulfate 
(SDS) and separation by SDS-polyacrylamide gel electro­
phoresis (SDS-PAGE). Both molecules are expressed on the 
surface of macrogametes or zygotes. Several monoclonal anti­
bodies (MAbs) reactive to these sexual-stage molecules block 
transmission of the parasites from the vertebrate host to the 
mosquito vector. Some of these MAbs suppress the infectivity 
of malaria gametocytes for mosquitoes in the presence of ac­
tive human complement (7, 15, 18, 20, 22). To answer the 
question whether MAb 63F2A2-mediated transmission block­
ade is isotype or epitope dependent, a number of isotype 
switch variants were prepared and selected for differences in 
their capacity to fix complement.
Downstream isotype switch variants occur spontaneously in 
hybridoma cell lines, with identical binding sites differing only 
in the heavy-chain isotype (9, 10). The frequency of spontane­
ously occurring isotypic switch variants ranges from 10~6 to 
10 per cell per generation (9, 16), and a sensitive assay is 
needed to detect the switched immunoglobulin isotype amid a 
large amount of immunoglobulin of the parental isotype. The 
technique of sequential sublining combined with screening by 
isotype-specific enzyme-linked immunosorbent assay (ELISA) 
has been proven before to be successful (2* 10).
* Corresponding author. Mailing address: Department of Medical 
Microbiology, University of Nijmegen, P.O. Box 9101,6500 HB Nijme­
gen, The Netherlands. Phone: +31-80-614664. Fax: +31-80-540216.
In this study, the importance of the immunoglobulin G 
(IgG) subclass for tTansmission-blocking activity is further an­
alyzed by production and testing of a number of switch variants 
of the anti-Pfs23Q-specific MAb 63F2A2.
MATERIALS AND METHODS
I
I
Parasites and Pfs230 extract. Mature gametocytes of P. falcipamm (isolate 
NF54) were produced in an automated large-scale culture system as described by 
Ponnudurai et al. (11). Gametbcyte isolation and Triton X-114 extraction of 
Pfs230 was obtained as described previously (20). The freeze-dried aqueous- 
phase extract was diluted in phosphate-buffered saline (PBS) and used as the 
antigen in both the competition and the one-site Pfs230 ELISA.
Antibodies, (i) MAbs. The anti-Pfs230 MAbs 18F25,63F2A2 (63F2A2.1), and 
63F2A2.1), and 63F3C8 (all isotype IgGl) and anti-Pfs25 MAb 32F81 (isotype 
IgG l) have been described previously (20, 22). MAb 18F25 was labelled with 
horseradish peroxidase by the periodate method described by Wilson and Na- 
kane (24). The labelled MAb was dialyzed against PBS-thimerosal (0.01%), and 
fetal calf serum (1%) was added and samples were stored at 4°C. MAbs 32F81 
and 18F25 were labelled with fluorescein isothiocyanate (FITC) by the method 
described by Goding (5). Rat MAbs against different mouse immunoglobulin 
isotyp.es, i.e., IgG l, IgG2a, and IgG2b, and horseradish peroxidase-labelled 
monoclonal rat anti-mouse kappa light-chain antibodies were purchased from 
CLB (Amsterdam, The Netherlands).
(ii) Complement. TyPe A® blood from Dutch blood bank donors with no 
previous malaria exposure was allowed to clot at room temperature for 1 h, and 
aliquots of the pooled serum were stored at -7ÖÜC until required. Freshly 
thawed samples were used only once as a source of complement. The serum was 
heated at 56°C for 30 min to inactivate complement activity. The serum was also 
used as a malaria-negative control serum in the transmission and parasite lysis 
tests.
Selection, enrichment, and purification of isotype switch variants. Selection 
and enrichment of isotype switch variants were conducted by the technique of 
sequential sublining (2,10). Briefly, the parental 63F2A2.1 hybridoma cells were 
grown in a 96-well microtiter plate (NUNC; Intermed), containing 1,000 cells per 
well, in Dulbecco’s modified Eagle’s medium supplemented with 20% fetal calf 
serum and 2.5 U  of interleukin 6 per ml and cultured in a humidified 5% 
C 0 2-in-air incubator at 37°C. After 7 days, the culture supernatants were tested 
in the isotype-specific ELISA and cells from positive wells were redistributed at 
50 cells per well. After a culture period of 4 days, the supernatants were tested, 
and cells of positive wells were subcultured at 2 cells per well and cloned by 
limiting dilution. Supernatants were tested for the presence of the parental 
isotype and/or switch variants.
Selected cloned lines were expanded in culture, and ascitic fluids were pro­
duced from 106 hybridoma cells injected in pristane-primed BALB/c mice. IgG 
was purified from ascitic fluid with a semiautomatic fast-performance liquid
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chromatography system (Pharmacia) equipped with a protein A  column (Phar­
macia) as described previously (20).
ELISAs. (i) Isotype-specific ELISA. The isotype-specific ELISA was used as 
described previously by Boot et al. (2). The reliable ELISA detection limits were
5 ng/ml for IgGl, IgG2b, and IgG2a with standard IgG isotype controls. Possible 
cross-reactivity between isotypes was below 0.1%.
(ii) Specific one-site ELISA. A  specific one-site ELISA for detection of anti­
bodies against Pfs230 was carried out as described previously (20).
All incubation steps were done at room temperature, except overnight incu­
bations which were done at 4°C. Between the different steps, plates were washed 
three times with PBS. The ELISAs were performed in duplicate, and the mean 
value of the optical densities was used for analysis.
Transmission blocking assay. The effect of MAbs on the infectivity of P. 
falciparum for Anopheles gambiae mosquitoes was tested in a bio assay using 
membrane feeders as described previously (12, 13, 22). Briefly, while the tem­
perature was maintained at 37°C, 14-day-old cultures containing fertile gameto- 
cytes were mixed with prewarmed uninfected erythrocytes and MAbs, introduced 
into prewarmed feeders, and fed to A. gambiae mosquitoes. All MAbs were 
tested separately in the feeder assay in the presence of active or inactivated 
human complement. Fully engorged mosquitoes were separated and held at 
26°C. Mosquitoes were dissected 7 days after feeding, the number of oocysts in 
each mosquito midgut was counted, and William’s mean (adjusted geometric 
mean [GM]) oocyst number was calculated (23). The adjusted GM was used to 
determine the reduction activity (20), and values greater than 85% were consis­
tent in subsequent experiments.
Suspension Immunofluorescence assay (SIFA). Molecules with an apparent 
molecular size by SDS-PAGE of 25 kDa (Pfs25) appear on the surface of 
macrogametes or zygotes some hours after zygote formation, and this occurrence 
was used as a marker o f the further development of sexual stages in vitro or in 
the mosquito midgut (feeder assay; see above).
Suspensions of 106 mature gametocytes in 100 jxl of RPMI 1640 medium were 
mixed with 100 of malaria-negative serum, 30 jxl of active or inactivated 
complement serum, and 10 |xl of parental MAb 63F2A2.2 or the respective 
switch variants (5 or 25 p.g in PBS) and incubated at 27°C for 3 h. Subsequently,
25 |xl of the suspension containing 105 parasites was added to 25 |jl1 of FITC- 
labelled MAb 32F81 diluted 1:40 in 0.05% Evans blue in PBS (pH 7.2)-2% 0.1 
M gIucose-0.1% 2.7 tnM Na2EDTA-0,05% sodium azide (PBG). The parasites 
were incubated for 1 mín, washed with phosphate-buffered glucose solution (i.e., 
PBG) containing 5% bovine serum (PBGB), centrifuged at 16,000 X g for 10 s, 
resuspended in 30 jxl of PBGB, and placed in a Bürker-Türk counting chamber, 
and Pfs25-positive macrogameles or zygotes were counted under a Leitz Or­
tholux fluorescence microscope (X500 magnification).
Isotype-dependent lysis of macrogamctes or zygotes. A  100-p.l suspension 
containing 106 vital mature gametocytes in RPMI 1640 medium was mixed with 
100 [jlI of malaria-negative serum and incubated at 27°C for 30 min. Twenty-five 
microliters of this suspension was incubated with 25 p.1 of FITC-labelled MAb 
18F25 for 20 min, and washed with PBGB by centrifugation at 16,000 X g for 10 
s, and the pellet was re suspended in 30 jjlI of PBGB. To this sample, 5 |xl (1 |uug) 
of the MAb 63F2A2 switch variant together with 4 p.1 of serum as a source of 
active or inactivated complement was added. Parasites were examined and 
scored as intact or lysed macrogametes or zygotes by both fluorescence and 
phase-contrast light microscopies (X500 magnification).
RESULTS
Isolation and characterization of switch variants. When 
seeded at 1,000 cells per well, IgG2b switch variants were 
detectable from the parental 63F2A2.1 hybridoma after 7 days 
of culture in one to two wells per microtiter plate. Further 
cloning and subcloning resulted in the isolation of a 63F2A2 
switch variant of the IgG2b subclass (63F2A2.2b). By use of a 
similar protocol, 63F2A2 MAbs of the IgG2a isotype (63F2A2. 
2a) were obtained from the 63F2A2.2b-producing hybridoma. 
All switch variants were subjected to limiting dilution condi­
tions to reach purity at the clonal level. The switch variants 
reacted only in the ELISA that was specific for the particular 
isotype (data not shown). Figure 1 shows similar binding pro­
files of the parental MAb 63F2A2.1 and its IgG2b and IgG2a 
switch variants in the Pfs230 one-site ELISA.
Transmission-blocking capacity of isotypes. The effect of 
IgG subclass specificity on transmission was analyzed in the 
bioassay in the presence of active or inactivated human com­
plement. In the presence of active complement, anti-Pfs230 
MAbs 63F2A2.2b and 63F2A2.2a suppressed infectivity of P. 
falciparum for mosquitoes by ^90% and ^99%, respectively, 
at concentrations of 1.0 [ig per feeder (Table 1). In the pres-
OD (460nm)
isotype switch variant in ng/ml
FIG. L Reactivity of IgG l, IgG2a, and IgG2b isotype variants of MAb 
63F2A2 in the one-site Pfs230 ELISA, Protein A-purified MAbs were serially 
diluted and ranged in concentration from 10 |xg/ml to 0.12 ng/ml in PTG. Results 
are expressed as the mean of duplicate incubations. OD, optical density.
ence of inactivated complement, the different isotypes of MAb 
63F2A2 had no significant effect relative to the mean of the 
three controls. MAb 63F2A2.1 did riot reduce oocyst number, 
irrespective of the presence of complement. Oocyst numbers 
of the control group with active complement were not signifi­
cantly different from those in the data of the inactivated com­
plement group (by paired-samples t test, t = 0.56, degrees of 
freedom [df] = 28, and P  = 0.58).
Table 2 shows the dose-dependent reduction of oocyst num­
bers in the presence of MAb 63F2A2.2b or 63F2A2.2a at 
concentrations ranging from 0.2 to 25 |xg per feeder (0.8 to 100 
fig/ml). Even at a concentration of 0.2 |jLg of MAb 63F2A2.2a 
per feeder, the GM number of oocysts was 0.9 with a standard 
deviation (SD) of 0.3 in the presence of active complement, 
which results in a reduction activity of 80%. In several inde­
pendent experiments, the reduction capacity of MAb 63F2A2. 
2b was lower than that of MAb 63F2A2.2a.
Twenty-five anti~Pfs230 MAbs of IgGl, IgG2b, or IgG2a in 
the form of heat-inactivated mouse ascites (final dilution, 
1:27), provided by R. Carter (17) or developed by one of us
TABLE 1. Effects of different isotypes of anti-Pfs230 MAb 63F2A2 
on infectivity of P. falciparum  gametocytes for A . gambiae 
mosquitoes in membrane-feeding experiments with
active or inactivated complement
MAb
63F2A2
isotype
Comple­
ment"
Oocyst count*
Expt 1 Expt 2
GMW SD R P/D GMW SD R P/D
1 + 24.3 5.9 24.5 20/20 2.9 0.9 0 24/20
1 — 20.7 3.6 35.7 20/20 2.7 1.1 5.6 27/30
2b + 3.2 0.7 90.1 18/20 0.2 0.1 93.9 5/20
2b — 21.7 4.5 32.6 20/20 2.4 0.8 14.3 14/20
2a + 0.2 0.1 99.4 4/20 0 0 100 0/20
2a — 27.2 3.3 25.6 20/20 3.3 1.1 0 24/30
Control* 32.2 6.5 58/59 2.8 1.4 51/59
a Active (+ )  or inactivated ( - )  human complement. 
b The data of experiment 2 are the combined results of two independent tests. 
GMW, William’s mean oocyst number (adjusted GM); SD, SD of the GMW; R, 
reduction activity according to the equation R = (Tc T,)TC X 100%, where T, 
is the GM for the test feeder and Tc is the GM of the three controls; P/D, number 
of oocyst-positive mosquitoes divided by number dissected. 
c Control is the mean of three feeders per experiment.
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TABLE 2. Infectivity of P. fa lc ipan im  gametocytes for mosquitoes 
in the presence of anti-Pfs230 MAb 63F2A2.2b or 63F2A2.2a at 
various concentrations with active or inactivated complement
300
Oocyst count/5 in presence of:
MAb conc Comple- 
(fxg/feeder) ment" MAb 63F2A2.2b MAb 63F2A2.2a
GMW SD R P/D GMW SD R P/D
25 + 3.2 0.7 90.1 18/20 0 0 100 0/20
25 — 20.7 3.6 35.7 20/20 4.3 1.1 4.9 18/20
5 + 3.0 0.7 90.7 17/20 0.1 0.1 99.8 2/20
5 — 24.2 4.3 24.5 21/21 3.3 1.0 27.0 16/20
1 + 9.5 2.1 70.5 19/20 0.1 0.1 99.8 2/20
1 — 27.3 6.1 15.2 20/20 4.5 1.3 0.4 17/20
0.2 + N D C 0.9 0.3 80.1 12/20
0.2 — N D 4.7 1.6 0 16/20
Control^ 32.2 6.5 58/59 4.5 1.3 46/59
a Active (+ )  or inactivated ( - )  human complement. 
h See Table 1, footnote b, for explanation of the different boxheads. 
c' ND, not done.
d Control is the mean of three feeders per experiment.
(N.K.), were then tested for the infectivity of P. falcipanim  
gametocytes to mosquitoes. Ten anti-Pfs230 MAbs (isotype 
IgG2a) and one MAb of isotype IgG2b (MAb 12A1A5) were 
all effective in blocking transmission but only when active com­
plement was added to the feeder, whereas 14 IgGl isotype 
MAbs were not (Table 3).
SIFA and complement-mediated lysis of macrogametes or 
zygotes. The mechanism of complement-dependent transmis­
sion-bio eking activity of MAbs 63F2A2.2b and 63F2A2.2a was 
further analyzed in vitro with activated gametocytes and a 
SIFA based on antibody reactivity to Pfs25, thereby monitoring 
development of macrogametes or zygotes 3 h after activation. 
The actual numbers of macrogametes or zygotes differ in sev­
eral parasite batches, which makes direct comparison of data 
of independent experiments impossible. In a representative 
experiment (Fig. 2), no statistically significant differences were 
found in macrogametes or zygote numbers between the differ­
ent isotypes and the controls (no MAb added) when inacti­
vated complement was added (e.g., by paired-sample t  test 
between IgG2a and control, t ~  1.37, df = 2, and P = 0.305). 
In addition, no significant difference was found between the 
numbers of macrogametes or zygotes for the control groups 
(absence of specific anti-Pfs230 MAb) with active complement 
in comparison with those of groups with inactivated comple­
ment (t — 4.13, df — 2, P  = 0.054). When the data of the 
control and the IgGl groups are compared with respect to the
TABLE 3. Effect of anti-Pfs230 MAbs in the presence of active 
complement on infectivity of P. falciparum (isolate NF54)
gametocytes for A. gambiae mosquitoes
MAbs Iso type Ra Source*’
5AS, 12C5, 8C10, 9C3, 4H2, 12B3, IgGl 0-24 I
14G8, 8D9
7E10H7, 9F2A10, 14D7, IgGl 0-35 II
14H10A2, 13H10E1, 2G8E5
11E3, 12F10, 1H2, 3G9, 7A6, IgG2a 100 I
8C11, 17E9, 4C10
12A1A5, 11C12F7, 21C1 IgG2a6‘ 100 II
a R, percentage of oocyst reduction in the transmission blocking assay. For 
formula, see Table 1, footnote b.
h Anti-Pfs230 MAbs were provided by R. Carter (17) (I) and developed by N. 
Kumar (II). 
c MAb 12A1A5 has an IgG2b isotype.
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FIG. 2. Effect of different isotypes of MAb 63F2A2 on the in vitro develop­
ment of macrogametes or zygotes as detected by the number of Pfs25~positive 
macrogametes or zygotes per microliter. Symbols: E ü , control; IgGl; EZZ3, 
IgG2b; , IgG2a.
effect of complement, a significant reduction was observed in 
the presence of active complement (t = 4.43, df =  5, P  =
0.007). Active complement in the presence of MAb 63F2A2.1 
had no effect, but in the presence of MAb 63F2A2.2b or 
63F2A2.2a, the number of macrogametes or zygotes was re­
duced substantially and almost completely in comparison with 
the effect of the control group (/ = 6.62, df = 2, and P  -  0.022 
versus t = 6.47, df = 2, and P  ~  0.023, respectively).
Lysis of macrogametes or zygotes by the complement-fixing 
MAb 63F2A2.2a in the presence of active or inactivated com­
plement is shown in fluorescent micrographs using SIFA and 
the FITC-labelled anti-Pfs230 MAb 18F25 (Fig. 3). In the 
absence of lysis, fluorescence was clearly visible at the circum­
ference of apparently intact parasites (Fig. 3A), whereas fluo­
rescence after lysis revealed either no round forms or damaged
A B
i
FIG. 3. Complement-mediated lysis of early P. falcipanim macrogametes or 
zygotes in the presence of MAb 63F2A2.2a as observed after staining with 
FITC-labelled MAb 18F25. The macrogametes or zygotes remained visually 
intact when incubated with the IgG2a switch variant in the presence of inacti­
vated complement (A) and were lysed in the presence of the IgG2a switch variant 
and active human complement (B).
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round forms with fluorescent debris or fluorescence of incom­
plete round forms (Fig. 3B). With phase-contrast light micros­
copy, damaged parasites with extrusion of the pigment or lo­
calization of aggregated pigment at peripheral sites and loss of 
pigment motility were manifested.
DISCUSSION
In the present study, downstream IgG2b and IgG2a switch 
variant antibodies specific for Pfs230 were generated from 
the parent MAb, 63F2A2.L In contrast to 63F2A2.1, both 
63F2A2.2b and 63F2A2.2a were able to block the transmission 
of P. falcipanim  to A. gambiae mosquitoes in membrane-feed­
ing experiments but only in the presence of active complement. 
Results from the one-site Pfs230 ELISA (Fig. 1) show that the 
dose-dependent bindings of MAbs 63F2A2.1, 63F2A2.2b, and 
63F2A2.2a to Pfs230 are comparable. SIFA results suggest a 
complement-dependent disturbance of the sexual development 
of macrogametes or zygotes after binding of 63F2A2.2b or 
63F2A2.2a switch variant MAbs. Even in the presence of active 
complement, parental MAb 63F2A2.1 did not prevent the de­
velopment of parasites after activation of the mature gameto­
cytes; however, irrespective of the presence of these MAbs, 
active complement shows a direct effect on macrogametes or 
zygote development (Fig. 2). This may be explained by an 
alternative activation of the complement cascade due to a 
direct interaction between C3 and the parasites similar to the 
stimulation observed with certain bacteria. Although some re­
duction in the number of viable parasites is accomplished by 
this activation of the alternative pathway of complement, this 
does not lead to transmission blockade. Whether this phenom­
enon applies to other epitopes of Pfs230 (20) remains to be 
determined.
All anti-Pfs230 MAbs of isotype IgG2b or IgG2a tested to 
date were effective in blocking transmission but only when 
complement was added to the feeder, whereas IgGl isotype 
MAbs were not. To date, there is an absolute correlation 
between Pfs230-related transmission blockade by MAbs, the 
ability of the isotype to fix complement, and the need for active 
complement to show transmission blockade by Pfs230-binding 
antibodies. Quakyi et al. (15) already described two Pfs230- 
specific MAbs (both IgG2a) that suppressed infectivity of P. 
falcipanim  to Anopheles freeborni mosquitoes by a comple­
ment-mediated lysis of early macrogametes or zygotes. A com­
parable effect of complement-fixing MAbs of the IgG2a iso type 
against a Plasmodium gallinaceum protein that is analogous to 
Pfs230 was described by Kaushal et al. (7). Confirming our 
observations, Read et al. (17) also found in a recent study the 
complement-dependent suppression of transmission of game­
tocytes of P. falcipanim 3D7 to mosquitoes with anti-Pfs230 
MAbs of isotype IgG2a.
Generally, mouse IgGl is known to be a poor binder of 
human complement factor Clq, whereas IgG2b and IgG2a 
bind Clq effectively. Binding of Clq is the first step in activa­
tion of the classical complement cascade, leading to the for­
mation of the membrane attack complex. Mouse IgG2a is 
more effective than IgG2b in fixation of human complement 
factors such as Clq, C4b, and C3b (3, 8). Although comple­
ment fixation in binding tests is not directly proportional to 
complement activation, haemolysis experiments suggest that 
the fixation of C3b is directly proportional to activation of C3b 
and the terminal lytic sequence (3). The capacity of different 
murine isotypes to fix complement fits perfectly the ability of 
MAb 63F2A2 switch variants to interfere with complement.
These results may have important implications for the study 
of anti-Pfs230 antibodies that are present in 40 to 85% of the
endemic human sera (6, 19). The presence of specific anti- 
Pfs230 antibodies in field sera has been associated with trans­
mission-blocking activity by some investigators (6) but could 
not be confirmed by others (14) or in our study (20). Immu­
noprécipitation and ELISA (6, 20) are based on epitope rec­
ognition by antibody being independent of the iso type, while a 
Pfs230-based transmission blockade may be accomplished by 
an isotype-dependent effector mechanism. When Pfs23Q com­
ponents are used in the design of a transmission-blocking vac­
cine (15), these findings support the need for an immunization 
strategy (1, 21) which should induce antibodies of a comple­
ment-binding isotype.
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